Semaglutide vs Tirzepatide Explained

Semaglutide and tirzepatide are both once-weekly injections used for weight management. They are related but not identical.
How they work
Semaglutide mimics GLP-1, a gut hormone that helps regulate appetite and fullness. Tirzepatide mimics both GLP-1 and GIP, a second gut hormone. Both slow stomach emptying and help many people feel full sooner.
What the research shows
In SURMOUNT-5, a 2025 head-to-head trial of the brand-name medications in adults with obesity and without diabetes, people taking tirzepatide lost an average of about 20 percent of their body weight over 72 weeks, compared with about 14 percent with semaglutide. Averages do not predict any one person's result.
Side effects
Both medications share similar side effects, mostly digestive: nausea, diarrhea, constipation and vomiting, especially when the dose increases. Both carry the same warning about medullary thyroid cancer and MEN2.
How to choose
Your provider considers your health history, goals, how you have responded to medications before, side effects and cost. Some people do well on either. Compounded versions are not FDA-approved.
Frequently asked questions
Can I switch from one to the other?
Sometimes. Your provider decides whether switching makes sense and what dose to start.
Are both injections?
Yes. Both are injected once a week.
Sources
Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. New England Journal of Medicine, 2025. U.S. FDA prescribing information for Wegovy and Zepbound.
Related programs
This article is for educational purposes only and is not medical advice. Talk to a licensed provider about your situation.
